Nexteligent Opportunity Assessment Acquisition Growth Strategy: OTC Markets Group Inc. OTC Pink Basic Disclosure Guidelines (v3 February 2021) Page 12 of 26 • Nexteligent continues to explore acquisition opportunities to expand its product and service offerings and geographic locations. • The Company has retained Corporate Finance Associates Worldwide (CFAW) to its support acquisition growth strategy with target identification, contract negotiations, due diligence, and funding. • Discovery is currently underway for three signed Letters of Intent (LOIs) that management anticipates closing before end-of-year 2021. • Nexteligent is working with CFAW to identify and acquire larger mid-sized companies with a collective revenue of $100,000,000. Additional Capital Requirements • In the near term, Nexteligent expects to begin a period of strategic expansion to fulfill our business objectives requiring additional capital from new and existing sources. • We intend to keep our existing and potential stockholders apprised of new business developments by building and implementing a public relations policy that includes quarterly stockholder communications and brand building. • The Company has an agreement in principle with 2 Watchmen, LLC, a Wyoming limited liability company in formation, to assist the Company in its proposed common stock buy-back program. The Company expects the proposed program will repurchase from $100,000 to $1,000,000 in Company common stock at market prices. • The Company has taken preliminary steps to list its common stock on the OTCQX Market, starting with a detailed audit conducted by a PCAOB accredited accounting firm and a review of the Company’s public disclosure and corporate structure by legal professionals with substantial public company experience. • The OTCQX the highest market tier of OTC Markets, requiring PCAOB audited financial statements and filing with the Securities and Exchange Commission (the “Commission”) as a reporting company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), with enhanced disclosure requirements and greater market liquidity. Organizational Design • Through its four specialized divisions, the Company delivers services and products that include revenue cycle management, preventative wellness and chronic care management, telemedicine and healthcare IT, and consulting services and marketing to healthcare providers spanning hospitals, clinics, doctors, home healthcare providers, labs, and skilled nursing and assisted living facilities. • Each company that joins the Nexteligent family maintains its operating structure, management team and workforce. Nexteligent Corporate works to achieve economies of scale, efficiencies, and cross selling opportunities. • Nexteligent’s organizational structure currently includes a Board of Directors that includes Majid Pishyar, Chairman; Paul Cristiano, Vice Chairman and CEO of Nexteligent Holdings, Inc.; Raymond Pomante, President and COO Nexteligent Holdings, Inc., and; Amin Pishyar, Outside Director. • The Company will feature an Operating Committee with senior executives from each operating entity to address strategic planning, service and product innovation, cross selling, and acquisition identification.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
